Close
Back to VERU Stock Lookup

(VERU) –

Nov 21, 2022 08:50 PM Bragar Eagel & Squire, P.C. Is Investigating Fox, Instil, Veru, and Twist and Encourages Investors to Contact the Firm
Nov 16, 2022 09:00 PM Bragar Eagel & Squire, P.C. Is Investigating Accelerate Diagnostics, and Veru and Encourages Investors to Contact the Firm
Nov 14, 2022 04:44 PM Form SC 13G/A VERU INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 10, 2022 05:37 PM Today's most important downgrades
Nov 10, 2022 04:30 PM U.S. stocks higher at close of trade; Dow Jones Industrial Average up 3.70%
Nov 10, 2022 07:47 AM Jefferies Downgrades Veru, Inc. (VERU) to Underperform
Nov 10, 2022 06:37 AM "Believe the FDA May Deny sabizabulin EUA" - Veru (VERU) PT Lowered at H.C. Wainwright
Nov 10, 2022 06:30 AM Veru (VERU): "See EUA More Likely Than Not " - Oppenheimer Reiterates Stock at Outperform, $36 PT
Nov 10, 2022 06:30 AM Veru (VERU): "See EUA More Likely Than Not " - Oppenheimer Reiterates Stock at Outperform, $36 PT
Nov 10, 2022 05:43 AM Veru (VERU) Announces FDA AdCom Voted 8-5 Against sabizabulin
Nov 9, 2022 08:55 PM Veru Provides Update on FDA Advisory Committee Meeting Regarding Emergency Use Authorization of Sabizabulin to Treat Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome
Nov 9, 2022 04:27 PM FDA Advisory Panel Votes 8-5 Against Backing Veru (VERU) Covid Drug
Nov 9, 2022 08:55 AM Veru, Inc. (VERU) Shares Halted Ahead of FDA Panel Meeting
Nov 7, 2022 12:04 PM Oppenheimer on Veru, Inc. (VERU): 'expect sabizabulin to be granted Emergency Use Authorization in the weeks following the ad comm'
Nov 7, 2022 10:11 AM FDA staff flags uncertainties on Veru's COVID drug; EUA hopes lift shares
Nov 7, 2022 08:57 AM Veru, Inc. (VERU) on Watch After FDA Releases Briefing Documents for Sabizabulin
Nov 4, 2022 05:53 PM Form 4 VERU INC. For: Nov 02 Filed by: Eisenberger Mario
Nov 4, 2022 05:47 PM Form 4 VERU INC. For: Nov 02 Filed by: Hyun Grace
Nov 4, 2022 05:40 PM Form 4 VERU INC. For: Nov 02 Filed by: Lu Lucy
Nov 4, 2022 05:35 PM Form 4 VERU INC. For: Nov 02 Filed by: Rankowitz Michael L
Nov 4, 2022 05:29 PM Form 4 VERU INC. For: Nov 02 Filed by: STEINER MITCHELL SHUSTER
Nov 4, 2022 05:23 PM Form 4 VERU INC. For: Nov 02 Filed by: Greco Michele
Nov 4, 2022 05:17 PM Form 4 VERU INC. For: Nov 02 Filed by: BARNETTE K GARY
Nov 4, 2022 05:10 PM Form 4 VERU INC. For: Nov 02 Filed by: FISCH HARRY
Oct 24, 2022 08:33 AM Veru, Inc. (VERU) Announces Late-Breaker Oral Presentation of Sabizabulin Treatment for Hospitalized Adults with COVID-19 on Supplemental Oxygen at Infectious Disease Week
Oct 24, 2022 08:30 AM Veru Announces Late-Breaker Oral Presentation of Sabizabulin Treatment for Hospitalized Adults with COVID-19 on Supplemental Oxygen at Infectious Disease Week 2022
Oct 13, 2022 08:30 AM Veru to Present Late-Breaker Oral Presentation of Sabizabulin Treatment for Hospitalized Adults with COVID-19 on Supplemental Oxygen at Infectious Disease Week 2022
Oct 4, 2022 04:30 PM Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Sep 21, 2022 08:30 AM Veru to Participate in the Cantor Oncology, Hematology & HemeOnc Conference on September 28th, 2022
Sep 19, 2022 12:16 PM Veru, Inc. (VERU) Confirms FDA has Updated Meeting Date for Advisory Committee Meeting to Review EUA for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for ARDS
Sep 19, 2022 12:15 PM Veru Announces FDA has Updated the Meeting Date for the Advisory Committee Meeting to Review Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for Acute Respi
Sep 19, 2022 11:18 AM UPDATE: Veru, Inc. (VERU) Declines 24% After FDA Panel Postponed by a Month
Sep 14, 2022 04:28 AM Implied Volatility Movement
Sep 13, 2022 05:06 AM Implied Volatility Movement
Sep 12, 2022 04:26 AM Implied Volatility Movement
Sep 9, 2022 05:31 AM Veru, Inc. (VERU) 3 calls to 1 put
Sep 9, 2022 05:13 AM Implied Volatility Movement
Sep 8, 2022 03:44 AM Veru, Inc. (VERU) October option IV elevated
Sep 8, 2022 03:32 AM Implied Volatility Movement
Sep 7, 2022 02:12 PM Veru, Inc. (VERU) option IV elevated amid wide price movement
Sep 7, 2022 01:46 PM Veru, Inc. (VERU) Confirms Date for FDA Advisory Committee Meeting to Review Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for ARDS
Sep 7, 2022 01:45 PM Veru Announces Date for FDA Advisory Committee Meeting to Review Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome
Sep 7, 2022 11:54 AM Veru, Inc. (VERU) Extends Decline, Down 19%
Sep 7, 2022 09:17 AM Veru, Inc. (VERU) Climbs 11%, Covid Treatment to Face FDA Panel on Oct. 6
Sep 6, 2022 08:30 AM Veru to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 12th, 2022
Aug 31, 2022 10:25 AM Veru, Inc. (VERU) option IV elevated at 272
Aug 31, 2022 09:15 AM Outlook for sabizabulin Unchanged - Oppenheimer Defends Veru (VERU) Despite Weakness
Aug 30, 2022 10:40 AM Veru, Inc. (VERU) puts active as shares sell off 12%
Aug 30, 2022 10:39 AM Veru, Inc. (VERU) Lower as Results Questioned
Aug 22, 2022 08:34 AM Veru, Inc. (VERU) Granted Expedited Provisional Registration Regulatory Pathway for Sabizabulin in Australia

Back to VERU Stock Lookup